CLINICAL EVALUATION GAP ANALYSIS CONSULTATION

Most manufacturers we speak to are not starting from zero. They have documentation. They have a Clinical Evaluation Report, or at least a working draft. They have invested months, sometimes longer, in building an evidence package they believe is defensible.

The uncertainty is whether it will hold up under Notified Body review.

That uncertainty has consequences. Proceeding to submission with unresolved evidence gaps often leads to delays, additional queries, and avoidable remediation work.

This consultation is designed to give you an earlier, independent view..